Trulance OverviewPlecanatide (brand name Trulance), is a drug approved in January 2017 by the FDA for the treatment of chronic idiopathic constipation (CIC). Plecanatide is an agonist of guanylate cyclase C. Plecanatide increases intestinal transit and fluid through a buildup of cGMP. See also Linaclotide, another guanylate cyclase-C agonist References ^ "FDA approves Trulance for Chronic Idiopathic Constipation". FDA.gov. U.S. Food and Drug Administration. Retrieved 20 January 2017. ^ "TRULA...
Read more Trulance Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Plecanatide
Recent Trulance Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 3mg